Magzo Tablets contain Ondansetron 4 mg in an uncoated orally disintegrating tablet formulation. Ondansetron is a selective 5-HT3 receptor antagonist that helps prevent and control nausea and vomiting by blocking serotonin signals involved in the vomiting reflex.
Key Features
- Contains Ondansetron 4 mg per orally disintegrating tablet.
- Belongs to the 5-HT3 receptor antagonist class of antiemetic medicines.
- Helps prevent and control nausea and vomiting.
- Orally disintegrating formulation for convenient administration.
- Suitable for use as directed by a qualified healthcare professional.
Composition
Each uncoated orally disintegrating tablet contains:
- Ondansetron – 4 mg
- Excipients – q.s.
Indication
Magzo Tablets are indicated for the prevention and treatment of nausea and vomiting, including nausea and vomiting associated with chemotherapy, radiotherapy and postoperative conditions, as prescribed by a qualified healthcare professional.
